following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
the situation has become so bad that a cross-party committee of politicians called it a.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation... taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..